Stockscreener 앱 받기
3.25
2.99%
-0.10
Olema Pharmaceuticals Inc 주식(OLMA)의 최신 뉴스
Pictet Asset Management Holding SA Boosts Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
HighTower Advisors LLC Makes New $510,000 Investment in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
10,352 Shares in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Bought by Teacher Retirement System of Texas - Defense World
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Olema Expands Team: 5 Key Hires Receive Equity Compensation Package - Stock Titan
Top Premarket Decliners - MarketScreener
Insiders Could Have Profited By Holding onto Olema Pharmaceuticals Shares Despite 13% Drop - simplywall.st
JPMorgan Chase & Co. Cuts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28.00 - MarketBeat
Olema Pharmaceuticals stock hits 52-week low at $3.86 By Investing.com - Investing.com South Africa
Olema Pharmaceuticals stock hits 52-week low at $3.86 - Investing.com
HighTower Advisors LLC Takes $510,000 Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
JPMorgan Chase & Co. Lowers Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28.00 - Defense World
Pier Capital LLC Acquires New Shares in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Bank of New York Mellon Corp Trims Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Oncology to Present Preclinical Data for OP-3136, a - GlobeNewswire
Victory Capital Management Inc. Cuts Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Cancer Breakthrough: New Drug Shows Powerful Anti-Tumor Effects in Prostate, Ovarian, Lung Cancers - Stock Titan
What is Lifesci Capital's Estimate for OLMA FY2025 Earnings? - MarketBeat
HC Wainwright Has Positive Forecast for OLMA Q1 Earnings - MarketBeat
What is HC Wainwright's Forecast for OLMA FY2029 Earnings? - MarketBeat
Olema Pharmaceuticals' (OLMA) "Outperform" Rating Reiterated at Oppenheimer - MarketBeat
HC Wainwright Reaffirms "Buy" Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Releases Earnings Results - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Posts Quarterly Earnings Results, Beats Estimates By $0.12 EPS - MarketBeat
Victory Capital Management Inc. Sells 758,412 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Equities Analysts Issue Forecasts for OLMA FY2029 Earnings - The AM Reporter
FY2025 EPS Estimate for Olema Pharmaceuticals Cut by Analyst - Defense World
HC Wainwright Issues Optimistic Outlook for OLMA Earnings - Defense World
Olema Pharmaceuticals Inc (OLMA) Shares Rise Despite Market Challenges - The News Heater
Olema Oncology Reports 2024 Financial and Clinical Progress - TipRanks
Olema Pharmaceuticals (NASDAQ:OLMA) Earns “Outperform” Rating from Oppenheimer - Defense World
What is HC Wainwright’s Forecast for OLMA FY2029 Earnings? - Defense World
HC Wainwright Reiterates “Buy” Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - Defense World
Olema Pharmaceuticals stock hits 52-week low at $3.94 By Investing.com - Investing.com Australia
Olema Pharmaceuticals stock hits 52-week low at $3.94 - Investing.com India
Olema Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Olema Oncology Reports Fourth Quarter and Full Year 2024 Financial and Operating Results - GlobeNewswire
Olema Oncology price target lowered to $25 from $30 at Oppenheimer - TipRanks
Olema Pharmaceuticals Q4 Net Loss Widens -March 18, 2025 at 04:37 pm EDT - Marketscreener.com
Olema Pharmaceuticals Inc Reports Q4 2024 EPS of -$0.63 and Net - GuruFocus.com
Olema Pharmaceuticals, Inc. SEC 10-K Report - TradingView
3.01%
자본화:
|
볼륨(24시간):